Analysis of CD58 As a Predictive Marker of Morphologic Response to Inotuzumab Ozogamicin in Patients with B-Cell Acute Lymphoblastic Leukemia
- Resource Type
- Article
- Source
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p6071-6071, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020